Sinopharm Group 

€2.23
51
-€0-0.09% 今天

統計

當日最高
2.24
當日最低
2.24
52週高點
2.37
52週低點
1.96
成交量
-
平均成交量
-
市值
6.95B
本益比
8.25
股息殖利率
3.66%
股息
0.08

即將到來

股息

3.66%股息殖利率
Aug 25
€0.08
Aug 24
€0.11
Aug 23
€0.11
Aug 22
€0.11
Aug 21
€0.09
10年成長
3.98%
5年成長
-1.79%
3年成長
-8.26%
1年成長
不適用

財報

19Mar預期
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
1.06
1.29
1.52
1.75
預期EPS
1.27656217776
實際EPS
1.32135383312

財務

1.21%利潤率
有盈利
2019
2020
2021
2022
2023
2024
153.61B營收
1.85B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 X2S.F 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Show more...
執行長
Mr. Wanyong Lian
員工
108217
國家
CN
ISIN
CNE100000FN7
WKN
000A0N99U

上市

0 Comments

分享你的想法

FAQ

Sinopharm Group 今天的股價是多少?
X2S.F 目前價格為 €2.23 EUR,過去 24 小時下跌了 -0.09%。在圖表上更密切關注 Sinopharm Group 股票的表現。
Sinopharm Group 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Sinopharm Group 的股票以代號 X2S.F 進行交易。
Sinopharm Group 的股價在上漲嗎?
X2S.F 股票較上週上漲 +2.3%,本月下跌 -1.94%,過去一年 Sinopharm Group 上漲 +1.41%。
Sinopharm Group 的市值是多少?
今天 Sinopharm Group 的市值為 6.95B
Sinopharm Group 下一次財報日期是什麼時候?
Sinopharm Group 將於 August 31, 2026 公布下一次財報。
Sinopharm Group 上一季度的財報如何?
X2S.F 上一季度的財報為每股 0.15 EUR,預估為 0.14 EUR,帶來 +3.51% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Sinopharm Group 去年的營收是多少?
Sinopharm Group 去年的營收為 153.61BEUR。
Sinopharm Group 去年的淨利是多少?
X2S.F 去年的淨收益為 1.85BEUR。
Sinopharm Group 會發放股息嗎?
是的,X2S.F 的股息每 年度 發放一次。每股最新股息為 0.08 EUR。截至今日,股息殖利率(FWD)% 為 3.66%。
Sinopharm Group 有多少名員工?
截至 April 01, 2026,公司共有 108,217 名員工。
Sinopharm Group 位於哪個產業?
Sinopharm Group從事於Health Care產業。
Sinopharm Group 何時完成拆股?
Sinopharm Group 最近沒有進行任何拆股。
Sinopharm Group 的總部在哪裡?
Sinopharm Group 的總部位於 CN 的 Shanghai。